TrialJournal of clinical hypertension (Greenwich, Conn.)2007

Efficacy and safety of treating stage 2 systolic hypertension with olmesartan and olmesartan/HCTZ: results of an open-label titration study.

Joseph L Izzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.